NFKB1 and COVID-19: Conversely, liver samples from patients with COVID-19 presented a significant 1.9-fold increase in AGTR1, a 1.8-fold increase in NFKB1, and a 1.2-fold increase in F3 (p < 0.001) (Table 1; Figure 2C).